StephenBruceBaylinMD

Endocrinology • Baltimore, MD

Professor, Oncology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Baylin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Baylin's full profile

Already have an account?

Office
1830 E Monument St # Med
Johns Hopkins Hospital
Baltimore, MD 21287

Education & Training

Duke University School of MedicineClass of 1968

Certifications & Licensure

MD State Medical License 1971 - 2014

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1981

Publications & Presentations

PubMed

4 citations
Clinical Significance of Plasma CD9-Positive Exosomes in HIV Seronegative and Seropositive Lung Cancer Patients
Foteinos Ioannis Dimitrakopoulos, Anastasia E. Kottorou, Kristen Rodgers, John Timothy Sherwood, Georgia Angeliki Koliou
Cancers. 2021-10-16
10 citations
Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53-Dependent Manner.
James I. McDonald, Noor Diab, Elisa Arthofer, Melissa Hadley, Tomas Kanholm
Cancer Research. 2021-10-15
3 citations
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.
Melissa B. Pappalardi, Kathryn Keenan, Mark Cockerill, Wendy A. Kellner, Alexandra Stowell
Nature Cancer. 2021-09-27

Abstracts/Posters

DNA Methyltransferase Inhibitors Promote Homologous Recombination Deficiency through Induction of Immune Signaling, Sensitizing Acute Myeloid Leukemia Cells to PARP In...
Stephen Baylin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Coriell Institute for Medical Research, Van Andel Institute Awarded Estimated $12.4 Million SPORE Grant from National Cancer InstituteSeptember 22nd, 2021
Remembering Mark Smith, Cancer Researchers Receive 2020 AAAS Fellow Distinction, and MoreJanuary 1st, 2021
Combination of Two Drugs Disrupts Cancer Cells' Ability to Survive DNA Damage, Study FindsOctober 15th, 2019
Join now to see all

Grant Support

DNA Methyltrasferase Gene Expression In Colon CancerNational Institute Of Environmental Health Sciences2009–2012
Development Research ProgramNational Cancer Institute2009–2012
Career Development ProgramNational Cancer Institute2009–2012
CA: Administrative CoreNational Cancer Institute2009–2012
Spore In Lung CancerNational Cancer Institute1996–2012
Methylation Of The Calcitonin Gene In Human TumorsNational Cancer Institute1986–2012
The Usc-Jhu Cancer Epigenome Characterization CenterNational Cancer Institute2009–2011
Program LeadershipNational Cancer Institute2006–2010
MicroarrayNational Cancer Institute2006–2010
CRCNational Cancer Institute2006–2010
The Environment And Epigenetic Gene Silencing In CancerNational Institute Of Environmental Health Sciences2006–2009
Cancer Genome Characterization Center At Johns HopkinsNational Cancer Institute2006–2009
Developmental Pathways, Cancer, And DNA HypermethylationNational Cancer Institute2005–2009
DNA Methyltransferase Gene Expression In Colon CancerNational Institute Of Environmental Health Sciences2002–2008
Regional Oncology Research CenterNational Cancer Institute2007
Lung Cancer--Developmental Research ProgramNational Cancer Institute1996–2002
Lung Cancer--Career DevelopmentNational Cancer Institute1996–2002
DNA Methylation/Neuroendocrine Differentiation--Marking Early State Lung CancerNational Cancer Institute1996–2002
DNA Methyltransferase Gene Expression In Colon CancerNational Cancer Institute1991–2000
Screening Cancer Genomes For CPG Island HypermethylationNational Cancer Institute1997–1999
Special Project On Research Excellence--Lung CancerNational Cancer Institute1993–1995
Tumor Progression In Small Cell Lung CancerNational Cancer Institute1988–1994
Regulation Of Tumor Progression In Small Cell Lung CanceNational Cancer Institute1993
Specialized Program Of Research Excellence/Lung CancerNational Cancer Institute1992
Regulating Tumor Progression In Small Cell Lung CancerNational Cancer Institute1991–1992
Neuroendocrine Differentiation In Human TumorsNational Cancer Institute1985–1986
DFMO In The Treatment Of Human Small Cell Lung CancerNational Cancer Institute1985